Cell Source, Inc. (CLCS)
OTCMKTS
· Delayed Price · Currency is USD
0.990
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Cell Source Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.02 | 0.02 | 0.22 | 0.09 | 0.24 | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 0.02 | 0.02 | 0.22 | 0.09 | 0.24 | 0.03 | Upgrade
|
| Cash Growth | 790.47% | -90.03% | 139.18% | -61.47% | 765.77% | 47.40% | Upgrade
|
| Prepaid Expenses | 0.24 | 0.16 | 0.16 | 0.2 | 0.18 | 0.06 | Upgrade
|
| Other Current Assets | 0 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 0.26 | 0.2 | 0.41 | 0.31 | 0.45 | 0.11 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0 | - | Upgrade
|
| Total Assets | 0.26 | 0.2 | 0.41 | 0.31 | 0.45 | 0.11 | Upgrade
|
| Accounts Payable | 2.04 | 1.47 | 0.68 | 0.22 | 0.19 | 0.14 | Upgrade
|
| Accrued Expenses | 5.53 | 4.75 | 4.22 | 3.12 | 3.08 | 2.42 | Upgrade
|
| Short-Term Debt | 9.11 | 8.22 | 7 | 4.66 | 3.31 | 1.59 | Upgrade
|
| Current Portion of Long-Term Debt | 0.99 | 1.08 | 0.91 | 1.83 | 1.49 | 0.97 | Upgrade
|
| Other Current Liabilities | 1.55 | 0.29 | 0.24 | 0.3 | 0.32 | 0.6 | Upgrade
|
| Total Current Liabilities | 19.21 | 15.81 | 13.04 | 10.14 | 8.4 | 5.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.15 | Upgrade
|
| Total Liabilities | 19.21 | 15.81 | 13.04 | 10.14 | 8.4 | 5.86 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 26.86 | 26.01 | 23.67 | 21.32 | 17.72 | 15.38 | Upgrade
|
| Retained Earnings | -45.85 | -41.67 | -36.35 | -31.18 | -25.71 | -21.15 | Upgrade
|
| Total Common Equity | -18.94 | -15.61 | -12.64 | -9.83 | -7.95 | -5.74 | Upgrade
|
| Shareholders' Equity | -18.94 | -15.61 | -12.63 | -9.83 | -7.95 | -5.74 | Upgrade
|
| Total Liabilities & Equity | 0.26 | 0.2 | 0.41 | 0.31 | 0.45 | 0.11 | Upgrade
|
| Total Debt | 10.1 | 9.3 | 7.9 | 6.5 | 4.81 | 2.7 | Upgrade
|
| Net Cash (Debt) | -10.07 | -9.27 | -7.68 | -6.4 | -4.56 | -2.67 | Upgrade
|
| Net Cash Per Share | -0.25 | -0.25 | -0.22 | -0.19 | -0.16 | -0.09 | Upgrade
|
| Filing Date Shares Outstanding | 43.47 | 41.02 | 38.16 | 34.44 | 32.66 | 27.08 | Upgrade
|
| Total Common Shares Outstanding | 43.25 | 39.83 | 36.08 | 34.36 | 32.54 | 27.08 | Upgrade
|
| Working Capital | -18.94 | -15.61 | -12.63 | -9.83 | -7.95 | -5.6 | Upgrade
|
| Book Value Per Share | -0.44 | -0.39 | -0.35 | -0.29 | -0.24 | -0.21 | Upgrade
|
| Tangible Book Value | -18.94 | -15.61 | -12.64 | -9.83 | -7.95 | -5.74 | Upgrade
|
| Tangible Book Value Per Share | -0.44 | -0.39 | -0.35 | -0.29 | -0.24 | -0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.